The RxPONDER trial and its impact on best clinical practice

WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine

The global platform for access to childhood cancer medicines

Cancer medicine shortages for children around the world

OncoAlert and ecancer round up: SABCS 2021

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL

Azacitidine, venetoclax and gilteritinib for FLT3-mutated AML

Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma

Latest in combination therapy for NDMM patients

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma.